BPC-157, which is short for Body Protection Compound 157, was discovered in human gastric juice in a lab led by Predrag Sikiric, a Croatian scientist
[1] Unlike the folic acid derivative leucovorin, folic acid is not clinically useful in offsetting the action of folate reductase inhibitors because it requires the enzyme dihydrofolate reductase for activation
Pernicious anemia is an autoimmune condition in which the body cannot absorb vitamin B12 properly
Most clients feel the effects within 24 to 48 hours of their injection
However, the exposure to BPC-157 appeared to significantly reduce plasma extravasation, histological alterations potentially associated with inflammation, and alveolar bone resorption
Early Human Evidence for Hair and Skin Outcomes Skin outcomes have more direct human evidence than hair outcomes